贝达奎林治疗耐药结核病患者的心脏风险因素:一项回顾性队列研究
Huang Yanxia1, Muhammad Tahir Khan2,3, Huang Xianlin4
1State Key Laboratory of Respiratory Disease, Guangzhou Key Laboratory of Tuberculosis Research, Department of Cardiovascular Medicine, Guangzhou Chest Hospital, Institute of Tuberculosis, Guangzhou Medical University, Guangzhou, China.
Cardiology
|November 21, 2025
概括
治疗耐药结核病 (DR-TB) 的贝达奎林通常会延长QT间隔,但 discontinuation是罕见的. 同时服用克洛法齐明和低血会增加心脏事件的风险,需要监测.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 贝达基林对于治疗耐药结核病 (DR-TB) 是至关重要的.
- 贝达基林的使用与QT间隔延长有关,需要对心脏安全性进行评估.
- 在DR-TB患者中评估贝达奎林治疗方案的心脏安全性和风险因素至关重要.
研究的目的:
- 在DR-TB患者中评估含贝达基林治疗方案的心脏安全性.
- 为了确定与贝达奎林治疗期间心脏不良事件相关的风险因素.
- 为贝达奎林治疗的临床应用和风险减轻策略提供信息.
主要方法:
- 对202名DR-TB患者进行了回顾性队列研究,这些患者接受了含贝达基林的治疗方案.
- 心脏安全评估包括心电图,心血管症状和24周的电解质监测.
- 统计分析确定了心脏不良事件的风险因素,包括同时服用药物和电解质失衡.
主要成果:
- 在19.80%的患者中出现QTcF延长 (≥60毫秒);一名患者的QTcF>500毫秒.
- 139名患者 (68.81%) 没有心脏事件,而44人 (21.78%) 经历了3级事件.
- 同时使用克洛法齐明 (OR=3.66) 和低血 (OR=24.77) 显著增加了等级≥3心脏事件的风险.
结论:
- 延长QT间隔是常见的,但很少导致在DR-TB患者中停用贝达奎林.
- 同时服用克洛法齐明和低血糖是心脏不良事件的重要危险因素.
- 常规电解质监测,补充剂和谨慎的联合处方建议用于贝达基林的DR-TB患者.
相关概念视频
01:28Pulmonary Tuberculosis V
530
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
530
01:29Pulmonary Tuberculosis I
811
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
811
01:26Pulmonary Tuberculosis IV
469
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
01:28Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
01:31Pulmonary Tuberculosis III
901
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
901
01:29Therapeutic Drug Monitoring: Affecting Factors
183
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
183